About ENTrigue Surgical
ENTrigue Surgical is an early commercial stage company that is developing several product platforms for the relatively underserved Ears, Nose, & Throat market. The company was founded in 2007 by an ENT surgeon (Dr. Donald Gonzales) and medical device industry executive (Fred Dinger). Among ENTrigue's first commercialized products are a line of articulating instruments; a septal stapling system utilizing resorbable staples; and a line of resorbable suture and tissue repair products based on a new class of polymers with a profile of strength, flexibility, and soft tissue compatibility that is when compared to existing resorbable polymers. In July 2013, ENTrigue Surgical was acquired by ArthroCare. The valuation of ENTrigue Surgical was $45 million. Other terms of the deal were not released.
ENTrigue Surgical Patents
ENTrigue Surgical has filed 10 patents.
Inflammations, Nose, Implants (medicine), Bones of the head and neck, Syndromes
Inflammations, Nose, Implants (medicine), Bones of the head and neck, Syndromes
Latest ENTrigue Surgical News
Mar 11, 2017
ENTrigue Surgical, Inc. Medical Equipment Deals and Alliances Profile [Updated: 23012017] Prices from USD $250 21:07 EST 10 Mar 2017 | BioPortfolio Reports Home » Topics » Surgical treatments » Latest News » ENTrigue Surgical, Inc. Medical Equipment Deals and Alliances Profile [Updated: 23012017] Prices from USD $250 Summary ENTrigue Surgical , Inc. ENTrigue is a medical device company that designs, develops and manufactures surgical instruments. The company offers products such as sinus dilation system, septal staplers, hemostatic gels, and articulating instruments. Its articulating instruments comprise vertical jaw articulating thrucutting forceps, horizontal jaw articulating thrucutting forceps, vertical jaw articulating grasping forceps and horizontal jaw articulating grasping forceps. The company offers sinus dilation systems such as sinus delivery instruments and sinus dilation balloons. It sells its products through a network of distributors in the US and abroad. ENTrigue is headquartered in San Antonio, Texas, the US. ENTrigue Surgical, Inc. Medical Equipment Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Medical eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News
ENTrigue Surgical Frequently Asked Questions (FAQ)
When was ENTrigue Surgical founded?
ENTrigue Surgical was founded in 2007.
Where is ENTrigue Surgical's headquarters?
ENTrigue Surgical's headquarters is located at 12672 Silicon Drive, San Antonio.
What is ENTrigue Surgical's latest funding round?
ENTrigue Surgical's latest funding round is Acquired.
How much did ENTrigue Surgical raise?
ENTrigue Surgical raised a total of $30.67M.
Who are the investors of ENTrigue Surgical?
Investors of ENTrigue Surgical include ArthroCare Corporation, Prism VentureWorks, The Vertical Group and TauTona Group.
Who are ENTrigue Surgical's competitors?
Competitors of ENTrigue Surgical include Xoft, NICO, Biorez, Tepha, MedShape and 7 more.
Compare ENTrigue Surgical to Competitors
Connective Orthopaedics is a medical device company focused on the repair of soft tissue injuries.
Pegasus Biologics is developing advanced bioimplants for soft tissue reinforcement for orthopedics, sports medicine, neurosurgical and spine applications
Tissue Regeneration Systems is a company focused on the field of skeletal reconstruction. The company's main offering involves a technology platform that provides solutions for tissue regeneration. The primary market for these services is the healthcare industry. It was founded in 2008 and is based in Plymouth, Michigan.
Regenesis is engaged in the development, manufacturing, and sale of biomedical devices that promote healing and skin wound closure more quickly and cost-effectively than existing standards of wound treatment. The company's devices are based on its Cell Proliferation Induction (CPI) technology, in which electromagnetic signals trigger the repair and regeneration of soft tissue cells.
NICO Corporation is a company focused on revolutionizing minimally invasive neurosurgery in the healthcare industry. The company offers patented technologies that integrate imaging and intervention, providing a safe and minimally disruptive approach to brain surgery. NICO primarily serves the healthcare sector, particularly in the field of neurosurgery. It was founded in 2007 and is based in Indianapolis, Indiana.
Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.